Status:
COMPLETED
Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients
Lead Sponsor:
Mayo Clinic
Conditions:
Gastrointestinal Bleeding
Complication of Internal Device
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to estimate the proportion of Ventricular Assist Device (VAD) patients with abnormal gastrointestinal bleeding as assessed by HemoQuant fecal occult blood test. Also, in p...
Eligibility Criteria
Inclusion
- Group 1 - cross sectional study. Patients with implanted non-pulsatile ventricular assist devices of any type and at any time after implantation
- Group 2 - prospective study. Patients with usual VAD indications will be invited to participate, when, in the opinion of their treating physician a VAD will be highly likely within one month.
Exclusion
- Unwillingness to provide stool samples for study
- Unwillingness to be followed for study endpoints.
- Unwillingness to follow dietary restrictions necessary for accurate HemaQuant measurement
Key Trial Info
Start Date :
June 22 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 22 2013
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT01415869
Start Date
June 22 2011
End Date
June 22 2013
Last Update
May 20 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Jacksonville, Florida, United States, 32224
2
Mayo Clinic
Rochester, Minnesota, United States, 55905